News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Brazil’s Fleury Laboratories Seeks to Raise $334 Million in IPO
November 30, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Brazilian medical services company Fleury and its shareholders said on Monday they plan to raise up to 582.3 million reais ($334 million) through an initial public offering that should be concluded by mid-December.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
IPO
2026 IPO stock tracker: How newly public biotechs are performing
August 5, 2026
·
1 min read
·
Gabrielle Masson
Job Trends
5 NextGen winners who went public this year (and which ones are hiring)
August 5, 2026
·
5 min read
·
Angela Gabriel
Earnings
Pfizer CEO defends $7B bolt-on M&A strategy as peers rush to buy
August 4, 2026
·
1 min read
·
Annalee Armstrong
Business
As portfolio erodes, BMS stands to gain a lot from rumored AstraZeneca merger
August 4, 2026
·
3 min read
·
Gabrielle Masson